Lichen International Limited
LICN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.85 | -158.20 | 0.08 | 74.75 |
| FCF Yield | -2.18% | -0.03% | 0.05% | 0.04% |
| EV / EBITDA | -299.20 | 804.73 | 1,385.82 | 1,463.07 |
| Quality | ||||
| ROIC | -8.83% | 14.33% | 18.69% | 22.33% |
| Gross Margin | 61.90% | 61.17% | 59.73% | 59.70% |
| Cash Conversion Ratio | 0.91 | 0.07 | 1.38 | 0.86 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.06% | 5.05% | 3.30% | 2.76% |
| Free Cash Flow Growth | -334.64% | -133.40% | 8.91% | 1.20% |
| Safety | ||||
| Net Debt / EBITDA | 15.90 | -1.98 | -1.97 | -1.20 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 235.87 | 177.46 | 107.19 | 92.13 |
| Cash Conversion Cycle | 62.70 | 41.59 | 37.36 | 47.13 |